The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea
Open accessAbstract
Purpose: To further clarify the relationship between total cholesterol and cancer, which remains unclear. Methods: We prospectively examined the association between total cholesterol and site-specific and all-cancer incidence among 1,189,719 Korean adults enrolled in the National Health Insurance Corporation who underwent a standardized biennial medical examination in 1992 to 1995 and were observed for 14 years until cancer diagnosis or death. Results: Over follow-up, 53,944 men and 24,475 women were diagnosed with a primary cancer. Compared with levels less than 160 mg/dL, high total cholesterol (≥ 240 mg/dL) was positively associated with prostate cancer (hazard ratio [HR], 1.24; 95% CI, 1.07 to 1.44; P trend = .001) and colon cancer (HR, 1.12; 95% CI, 1.00 to 1.25; P trend = .05) in men and breast cancer in women (HR, 1.17; 95% CI, 1.03 to 1.33; P trend = .03). Higher total cholesterol was associated with a lower incidence of liver cancer (men: HR, 0.42; 95% CI, 0.38 to 0.45; P trend < .001; women: HR, 0.32; 95% CI, 0.27 to 0.39; P trend < .001), stomach cancer (men: HR, 0.87; 95% CI, 0.82 to 0.93; P trend ≤ .001; women: HR, 0.86; 95% CI, 0.77 to 0.97; P trend = .06), and, in men, lung cancer (HR, 0.89; 95% CI, 0.82 to 0.96; P trend < .001). Results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis B surface antigen status (men: HR, 0.60; P trend < .001; women: HR, 0.46; P trend = .003) and exclusion of the first 10 years of follow-up (men: HR, 0.59; P trend < .001; women: HR, 0.44; P trend < .001). Total cholesterol was inversely associated with all-cancer incidence in both men (HR, 0.84; 95% CI, 0.81 to 0.86; P trend < .001) and women (HR, 0.91; 95% CI, 0.87 to 0.95; P trend < .001), but these associations were attenuated after excluding incident liver cancers (men: HR, 0.95; P trend < .001; women: HR, 0.98; P trend = .32). Conclusion: In this large prospective study, we found that total cholesterol was associated with the risk of several different cancers, although these relationships differed markedly by cancer site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002
Carroll, M. D. (2005) · JAMA · doi:10.1001/jama.294.14.1773 · Cited by 531
Serum Lipid and Lipoprotein Patterns in Patients With Liver Cirrhosis and Chronic Active Hepatitis
Cicognani, C. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.7.792 · Cited by 233
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer
Ahn, J., Lim, U., Weinstein, S. J., Schatzkin, A., Hayes, R. B., Virtamo, J., & Albanes, D. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1248 · Cited by 207
Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
Crawford, E. D. (2009) · Urology · doi:10.1016/j.urology.2009.03.001 · Cited by 174
Serum cholesterol levels in relation to the incidence of cancer: The JPHC study cohorts
Iso, H., Ikeda, A., Inoue, M., Sato, S., & Tsugane, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24668 · Cited by 150
Serum Cholesterol and Cancer Risk: An Epidemiologic Persepective
Kritchevsky, S. B., & Kritchevsky, D. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.002135 · Cited by 146
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.
Eliassen, A. H., & Hankinson, S. E. (2008) · PubMed · Cited by 141
Association between plasma cholesterol and prostate cancer in the PSA era
Platz, E. A., Clinton, S. K., & Giovannucci, E. L. (2008) · International Journal of Cancer · doi:10.1002/ijc.23715 · Cited by 140
Schatzkin, A., Hoover, R. N., Taylor, P. R., et al. (1988) · PubMed · Cited by 131
Cited by
Seong, S. C., Kim, Y.-Y., Park, S. K., Khang, Y. H., Kim, H. C., Park, J. H., Kang, H.-J., Do, C.-H., Song, J.-S., Lee, E.-J., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016640 · Cited by 830
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Lu, L., Mullins, C. S., Schafmayer, C., Zeißig, S., & Linnebacher, M. (2021) · Cancer Communications · doi:10.1002/cac2.12220 · Cited by 303
Qin, W.-H., Yang, Z.-S., Li, M., Chen, Y., Zhao, X.-F., Qin, Y.-Y., Song, J.-Q., Wang, B.-B., Yuan, B., Cui, X.-L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.028 · Cited by 209
Hypercholesterolemia Induces Angiogenesis and Accelerates Growth of Breast Tumors In Vivo
Pelton, K., Coticchia, C. M., Curatolo, A. S., Schaffner, C. P., Zurakowski, D., Solomon, K. R., & Moses, M. A. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.03.006 · Cited by 109
Metadata
- Authors
- Kitahara, C. M., Berrington de González, A., Freedman, N. D., Huxley, R., Mok, Y., Jee, S. H., & Samet, J. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-04-20
- Volume
- 29
- Issue
- 12
- Pages
- 1592-1598
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2138331892
- Cited by
- 408
- References
- 29
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea. https://app.cochat.ai/papers/10.1200/jco.2010.31.5200
- The paper
- Kitahara, C. M., Berrington de González, A., Freedman, N. D., Huxley, R., Mok, Y., Jee, S. H., & Samet, J. M. (2011). Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2010.31.5200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.